Correlation Between Elevation Oncology and Hookipa Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Hookipa Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Hookipa Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevation Oncology and Hookipa Pharma, you can compare the effects of market volatilities on Elevation Oncology and Hookipa Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Hookipa Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Hookipa Pharma.

Diversification Opportunities for Elevation Oncology and Hookipa Pharma

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Elevation and Hookipa is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Hookipa Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hookipa Pharma and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Hookipa Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hookipa Pharma has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Hookipa Pharma go up and down completely randomly.

Pair Corralation between Elevation Oncology and Hookipa Pharma

Given the investment horizon of 90 days Elevation Oncology is expected to generate 1.2 times more return on investment than Hookipa Pharma. However, Elevation Oncology is 1.2 times more volatile than Hookipa Pharma. It trades about 0.04 of its potential returns per unit of risk. Hookipa Pharma is currently generating about -0.49 per unit of risk. If you would invest  60.00  in Elevation Oncology on August 28, 2024 and sell it today you would earn a total of  1.00  from holding Elevation Oncology or generate 1.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Elevation Oncology  vs.  Hookipa Pharma

 Performance 
       Timeline  
Elevation Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Elevation Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Hookipa Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hookipa Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Elevation Oncology and Hookipa Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elevation Oncology and Hookipa Pharma

The main advantage of trading using opposite Elevation Oncology and Hookipa Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Hookipa Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hookipa Pharma will offset losses from the drop in Hookipa Pharma's long position.
The idea behind Elevation Oncology and Hookipa Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum